Parnell Pharmaceuticals Holdings Ltd Company Profile (NASDAQ:PARN)

About Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)

Parnell Pharmaceuticals Holdings Ltd logoParnell Pharmaceuticals Holdings Limited is a veterinary pharmaceutical company. The Company is focused on developing, manufacturing and commercializing animal health solutions. The principal activities of the Company include manufacture for global sale of animal pharmaceutical product, and research and development of pharmaceutical products for global animal health markets. The Company operates through four segments: Companion Animal, Production Animal-U.S., Production Animal-Rest of World and Manufacturing Operations. It augments its pharmaceutical products with its FETCH and mySYNCH software platforms. It offers disease-modifying product, Zydax, for the treatment of osteoarthritis (OA). Its reproductive hormone products include estroPLAN and GONAbreed. It has a nutraceutical product, Glyde. It also markets a non-steroidal anti-inflammatory drug (NSAID), called Tergive. It is developing a pipeline of clinical drug candidates, such as PAR 121, PAR 122, PAR 101, PAR 081 and PAR 061.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Symbol: NASDAQ:PARN
  • CUSIP: N/A
  • Web: www.parnell.com/
Average Prices:
  • 50 Day Moving Avg: $1.03
  • 200 Day Moving Avg: $1.38
  • 52 Week Range: $0.65 - $3.95
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.21
  • P/E Growth: 0.0000
Profitability:
  • Net Margins: -130.46%
  • Return on Equity: -83.86%
  • Return on Assets: -43.24%
Debt:
  • Debt-to-Equity Ratio: 0.82%
  • Current Ratio: 0.61%
  • Quick Ratio: 0.37%
Misc:
  • Average Volume: 85,051 shs.
  • Beta: 0.14
 

Frequently Asked Questions for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)

What is Parnell Pharmaceuticals Holdings Ltd's stock symbol?

Parnell Pharmaceuticals Holdings Ltd trades on the NASDAQ under the ticker symbol "PARN."

Who are some of Parnell Pharmaceuticals Holdings Ltd's key competitors?

Who are Parnell Pharmaceuticals Holdings Ltd's key executives?

Parnell Pharmaceuticals Holdings Ltd's management team includes the folowing people:

  • Alan Bell, Chairman of the Board
  • Robert Joseph, President, Chief Executive Officer, Director
  • Brad McCarthy, Chief Financial Officer, Director
  • Edward J. Robb, Chief Scientific Officer
  • Matthew Musselman, Chief Commercial Officer
  • Peter Molloy, Independent Director
  • Andrew J. Want, Independent Director

How do I buy Parnell Pharmaceuticals Holdings Ltd stock?

Shares of Parnell Pharmaceuticals Holdings Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Parnell Pharmaceuticals Holdings Ltd's stock price today?

One share of Parnell Pharmaceuticals Holdings Ltd stock can currently be purchased for approximately $0.69.


MarketBeat Community Rating for Parnell Pharmaceuticals Holdings Ltd (NASDAQ PARN)
Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  40 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  100
MarketBeat's community ratings are surveys of what our community members think about Parnell Pharmaceuticals Holdings Ltd and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/24/2016Dawson JamesReiterated RatingBuyN/AView Rating Details
4/1/2016Jefferies Group LLCReiterated RatingBuy$18.00 -> $16.00N/AView Rating Details
2/29/2016Piper Jaffray CompaniesReiterated RatingOverweight$12.00 -> $9.00N/AView Rating Details
(Data available from 9/22/2015 forward)

Earnings

Earnings History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Earnings by Quarter for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Earnings History by Quarter for Parnell Pharmaceuticals Holdings Ltd (NASDAQ PARN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/21/2015Q3($0.22)($0.13)ViewListenView Earnings Details
8/11/2015Q2($0.26)($0.19)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Current Year EPS Consensus Estimate: $-1.5200 EPS
Next Year EPS Consensus Estimate: $-0.5700 EPS

Dividends

Dividend History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Latest Headlines for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Source:
DateHeadline
americanbankingnews.com logoParnell Pharmaceuticals Holdings (PARN) vs. Allergan PLC. (AGN) Head-To-Head Review
www.americanbankingnews.com - August 27 at 6:08 PM
americanbankingnews.com logoComparing Parnell Pharmaceuticals Holdings (PARN) & Mylan N.V. (MYL)
www.americanbankingnews.com - August 26 at 12:18 PM
americanbankingnews.com logoParnell Pharmaceuticals Holdings (NASDAQ:PARN) and Mylan N.V. (MYL) Financial Comparison
www.americanbankingnews.com - August 12 at 8:12 PM
americanbankingnews.com logoHead to Head Survey: Parnell Pharmaceuticals Holdings (NASDAQ:PARN) vs. Mylan N.V. (MYL)
www.americanbankingnews.com - August 6 at 2:22 PM
americanbankingnews.com logoComparing Mylan (MYL) & Parnell Pharmaceuticals Holdings (PARN)
www.americanbankingnews.com - August 1 at 6:32 PM
americanbankingnews.com logoParnell Pharmaceuticals Holdings (NASDAQ:PARN) vs. Sophiris Bio (SPHS) Critical Contrast
www.americanbankingnews.com - July 4 at 8:24 AM
americanbankingnews.com logoHead to Head Contrast: Juniper Pharmaceuticals (JNP) & Parnell Pharmaceuticals Holdings (PARN)
www.americanbankingnews.com - June 20 at 2:47 PM
americanbankingnews.com logoFlexion Therapeutics (FLXN) vs. Parnell Pharmaceuticals Holdings (PARN) Head to Head Review
www.americanbankingnews.com - June 7 at 7:58 AM
finance.yahoo.com logoEdited Transcript of PARN earnings conference call or presentation 24-May-17 9:00pm GMT
finance.yahoo.com - May 26 at 5:44 AM
seekingalpha.com logoParnell Pharmaceuticals Holdings (PARN) Business Results Update Conference (Transcript)
seekingalpha.com - May 25 at 12:20 AM
feeds.benzinga.com logoParnell to Report Business Update for the Three Months Ended March 31, 2017 on May 24, 2017
feeds.benzinga.com - May 19 at 12:49 AM
finance.yahoo.com logoEdited Transcript of PARN earnings conference call or presentation 21-Mar-17 9:00pm GMT
finance.yahoo.com - March 22 at 7:05 PM
biz.yahoo.com logoQ4 2016 Parnell Pharmaceuticals Holdings Ltd Earnings Release - 4:00 pm ET
biz.yahoo.com - March 21 at 11:08 AM
globenewswire.com logoParnell to Report Financial Results for Fiscal Year 2016 on March 22, 2017 - GlobeNewswire (press release)
globenewswire.com - February 23 at 7:13 PM
streetinsider.com logoForm 25 Parnell Pharmaceuticals - StreetInsider.com - StreetInsider.com
www.streetinsider.com - December 22 at 12:59 AM
streetinsider.com logoParnell Pharmaceuticals (PARN) Files to Voluntarily Delist from NASDAQ
www.streetinsider.com - December 20 at 6:33 PM
globenewswire.com logoParnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ - GlobeNewswire (press release)
globenewswire.com - December 20 at 1:31 PM
finance.yahoo.com logoPARN: Voluntarily Moving From the Nasdaq to the OTC…
finance.yahoo.com - December 15 at 8:07 PM
feeds.benzinga.com logo15 Biggest Mid-Day Losers For Monday
feeds.benzinga.com - December 12 at 2:38 PM
us.rd.yahoo.com logo3:02 am Parnell Pharmaceuticals intends to move from the NASDAQ OMX Global Market; expects to move to the OTC Pink open market
us.rd.yahoo.com - December 12 at 9:49 AM
globenewswire.com logoParnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and ... - GlobeNewswire (press release)
globenewswire.com - December 9 at 7:05 PM
globenewswire.com logoParnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility - GlobeNewswire (press release)
globenewswire.com - November 24 at 9:57 AM
finance.yahoo.com logo3:16 am Parnell Pharmaceuticals receives $20 million, senior secured, non-dilutive, term loan agreement with SWK Holdings
finance.yahoo.com - November 23 at 9:56 AM

Social

Chart

Parnell Pharmaceuticals Holdings Ltd (PARN) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by MarketBeat.com Staff